Shine Investment Advisory Services’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $24K | Hold |
247
| – | – | 0.01% | 425 |
|
|
2020
Q2 | $30K | Buy |
247
+107
| +76% | +$13K | 0.01% | 397 |
|
|
2020
Q1 | $12K | Buy |
140
+27
| +24% | +$2.31K | 0.01% | 497 |
|
|
2019
Q4 | $12K | Hold |
113
| – | – | ﹤0.01% | 545 |
|
|
2019
Q3 | $10K | Buy |
113
+64
| +131% | +$5.66K | ﹤0.01% | 556 |
|
|
2019
Q2 | $4K | Hold |
49
| – | – | ﹤0.01% | 636 |
|
|
2019
Q1 | $4K | Hold |
49
| – | – | ﹤0.01% | 645 |
|
|
2018
Q4 | $3K | Sell |
49
-49
| -50% | -$3K | ﹤0.01% | 641 |
|
|
2018
Q3 | $12K | Hold |
98
| – | – | 0.01% | 500 |
|
|
2018
Q2 | $10K | Sell |
98
-64
| -40% | -$6.53K | 0.01% | 525 |
|
|
2018
Q1 | $13K | Hold |
162
| – | – | 0.01% | 494 |
|
|
2017
Q4 | $13K | Hold |
162
| – | – | 0.01% | 501 |
|
|
2017
Q3 | $10K | Hold |
162
| – | – | 0.01% | 528 |
|
|
2017
Q2 | $7K | Buy |
+162
| New | +$7K | ﹤0.01% | 574 |
|